SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-001521
Filing Date
2018-05-08
Accepted
2018-05-08 16:12:09
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1821607.htm 10-Q 575015
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 13281
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 12861
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5478
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5418
  Complete submission text file 0001178913-18-001521.txt   2706378

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fomx-20180331.xml EX-101.INS 454625
7 XBRL TAXONOMY EXTENSION SCHEMA fomx-20180331.xsd EX-101.SCH 30019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20180331_cal.xml EX-101.CAL 50607
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20180331_def.xml EX-101.DEF 86963
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20180331_lab.xml EX-101.LAB 243677
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20180331_pre.xml EX-101.PRE 172249
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36621 | Film No.: 18814670
SIC: 2833 Medicinal Chemicals & Botanical Products